MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$20,731K
Net Income
-$5,898K
Net Profit Margin
-28.45%
EPS
-$0.11
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
20,731
17,699
45,891
19,990
Research and development
4,712
5,829
7,360
8,112
Selling, general and administrative
14,176
17,720
18,519
18,333
Restructuring expenses
4,031
3,633
-
-
Transaction-related expenses
6,089
-
-
-
Total expenses
29,008
27,182
25,879
26,445
Gain from operations
-8,277
-9,483
20,012
-6,455
Net loss on realized contingent milestone and royalty assets
-
-
37,500*
-
Trelegy milestone income
-
-
12,500*
-
Interest expense (non-cash)
-
-
582
573
Interest and other income, net
3,486
3,013
3,638
4,139
Income (loss) before income taxes
-4,791
-6,470
73,068
-2,889
Provision for income tax (expense) benefit
1,107
-1,537
12,044
-6,504
Net income (loss)
-5,898
-4,933
61,024
3,615
Net unrealized gain on available-for-sale investments
-
-
-
42
Total comprehensive income (loss)
-
-
-
3,657
Basic EPS
-0.11
-0.1
1.199
0.07
Diluted EPS
-0.11
-0.1
1.136
0.07
Basic Average Shares
51,667,000
51,279,000
50,865,000
50,520,000
Diluted Average Shares
51,667,000
51,279,000
53,688,000
51,908,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net income (loss)
-$5,898K
(-110.76%↓ Y/Y)
Income (loss) before
income taxes
-$4,791K
(-106.54%↓ Y/Y)
Provision for income tax
(expense) benefit
$1,107K
(-93.97%↓ Y/Y)
Interest and other
income, net
$3,486K
(139.26%↑ Y/Y)
Gain from operations
-$8,277K
(-203.74%↓ Y/Y)
Total revenues
$20,731K
(-20.86%↓ Y/Y)
Total expenses
$29,008K
(0.30%↑ Y/Y)
Selling, general and
administrative
$14,176K
(-23.08%↓ Y/Y)
Transaction-related expenses
$6,089K
Research and development
$4,712K
(-55.08%↓ Y/Y)
Restructuring expenses
$4,031K
Buy us a coffee
Theravance Biopharma, Inc. (TBPH)
Theravance Biopharma, Inc. (TBPH)